Compare TNC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNC | EVO |
|---|---|---|
| Founded | 1870 | 1993 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 778.3M |
| IPO Year | 1994 | 2007 |
| Metric | TNC | EVO |
|---|---|---|
| Price | $68.68 | $1.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $79.00 | $7.00 |
| AVG Volume (30 Days) | ★ 236.1K | 46.0K |
| Earning Date | 05-04-2026 | 04-08-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $1,137,600,000.00 | N/A |
| Revenue This Year | $5.77 | $1.37 |
| Revenue Next Year | $4.95 | $10.05 |
| P/E Ratio | $151.24 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.18 | $1.89 |
| 52 Week High | $91.93 | $4.27 |
| Indicator | TNC | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 34.61 | 40.09 |
| Support Level | $62.03 | $1.90 |
| Resistance Level | $77.95 | $2.20 |
| Average True Range (ATR) | 3.53 | 0.05 |
| MACD | -0.56 | 0.02 |
| Stochastic Oscillator | 11.33 | 17.74 |
Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.